anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

217,801-217,860 of 319,975

filter-aware
28
The chart demonstrates deepening clinical responses over time for NXC-201 therapy.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
29
The table displays clinical trial data for NXC-201, specifically focusing on safety profiles and management interventions.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
30
The slide highlights specific safety metrics (CRS and ICANS) for two dosage groups (100x10^6 and 300x10^6 cells).Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
31
The slide uses a step-wise process diagram to illustrate dose escalation.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
32
The slide features a scientific illustration of cellular structures, likely representing the drug's mechanism of action or target environment.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
33
Includes scientific diagrams of molecular pathways and efficacy data charts.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
34
Slide contains three distinct charts comparing IMX-110 against standard of care and other combinations in mouse models.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
35
Includes a process diagram illustrating the mechanism of action of IMX-110 in turning cold tumors hot.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
36
Includes Kaplan-Meier survival curves and bioluminescence imaging of tumor activity.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
37
Immix Biopharma | Investor Presentation Deck | 57 slidesImmix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
38
Includes waterfall charts and longitudinal patient response plots. Source note provided at bottom.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
39
The slide uses a bubble chart to map clinical trials and a table to summarize drug performance metrics, highlighting low efficacy and high toxicity.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
40
The slide uses a combination of a conceptual chart and a data table to highlight efficacy and safety in a small sample size (n=4).Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
41
The slide uses a process flow diagram to show trial progression for two distinct treatment arms.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
42
Immix Biopharma | Investor Presentation Deck | 57 slidesImmix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
43
The slide uses a process-flow layout to connect platform capabilities to specific product outputs.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
44
The slide uses a '3 Pillars' framework to explain the platform foundation, followed by a product-specific breakdown.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
45
Includes technical diagrams of the drug delivery mechanism and comparative survival data.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
46
Includes two sets of charts: tumor volume over time and survival curves. References specific dosing schedules and study parameters.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
47
Includes detailed scientific diagrams of the drug mechanism and clinical trial results.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
48
Immix Biopharma | Investor Presentation Deck | 57 slidesImmix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
49
The slide is divided into two sections: ImmixBio Clinical Advisory Board (top) and Select Nexcella Scientific Advisory Board (bottom).Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
50
Immix Biopharma | Investor Presentation Deck | 57 slidesImmix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
51
The slide is organized into two rows, one for each company's board members, featuring headshots, names, titles, and company logos.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
52
The slide uses a numbered list format to present key value propositions.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
53
Immix Biopharma | Investor Presentation Deck | 57 slidesImmix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
54
Highlights NXC-201's lower fludarabine dose and Carvykti's longer infusion window.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
55
The slide uses a combination of expert testimonials and a comparative clinical trial table to validate the outpatient administration model.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
56
The slide uses a bar chart to contrast the combined annual sales of two sets of oncology drugs.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
57
The slide compares efficacy benchmarks of established competitors (AbbVie, J&J, Takeda) to set a baseline for the IMX-120 opportunity.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
01
Slide 1
Independent Bank Corp | Results Presentation Deck | 27 slidesIndependent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Attention1 hit
02
Independent Bank Corp | Results Presentation Deck | 27 slidesIndependent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Attention1 hit
03
Independent Bank Corp | Results Presentation Deck | 27 slidesIndependent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Attention1 hit
04
Independent Bank Corp | Results Presentation Deck | 27 slidesIndependent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
The slide uses a combination of a donut chart for composition and a combo bar-line chart for cost/volume trends.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The chart uses a dual-axis approach to correlate interest rate trends with deposit volume growth.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Includes FDIC logo and 'Be Independent' branding.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
The slide uses two donut charts to visualize the composition of the loan portfolio, with a note clarifying the total portfolio value and the split between C&I and investment real estate.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
09
Includes two footnotes regarding exclusions and specific data adjustments.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
The slide highlights capital stability and regulatory compliance.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
11
The slide uses a combination of a multi-line chart for yields/margins and a bar chart for net interest income.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The slide uses a waterfall-style logic for the NIM changes on the left and a comparative financial table on the right.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The slide presents a sensitivity analysis of NII under various interest rate scenarios (+/- 100/200 bps).Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The slide uses a combination of a donut chart for composition and a combo bar-line chart for trends.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The slide uses a stacked bar chart for expenses and a bar chart for the efficiency ratio to illustrate cost management.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The slide uses a matrix structure to compare forward-looking guidance against recent quarterly performance.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Satisfaction1 hit
17
The slide uses a matrix structure to compare forward-looking guidance against realized quarterly performance.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Action1 hit
18
The slide uses a 2x2 grid layout to categorize strategic initiatives.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Action1 hit
19
Independent Bank Corp | Results Presentation Deck | 27 slidesIndependent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Action1 hit
20
Independent Bank Corp | Results Presentation Deck | 27 slidesIndependent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
21
Includes a table of liquidity sources and a grouped bar chart showing liquidity coverage ratios over time.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
22
Includes FDIC logo and disclaimer at bottom.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
23
Slide 23 of a presentation deck.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
24
Includes FDIC logo and 'Be Independent' branding.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
25
The slide title 'Non-GAAP to GAAP Reconciliation' appears slightly mislabeled as the table presents standard GAAP financial metrics (Net Interest Income, Net Income, etc.) rather than a reconciliation of non-GAAP measures.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
26
Standard financial disclosure slide for non-GAAP metrics.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
27
The table reconciles Common shareholders' equity to Tangible common equity and Total assets to Tangible assets to derive the Tangible common equity ratio.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
01
Slide 1
Jefferies Financial Group | Investor Presentation Deck | 74 slidesJefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations Beat · Setup1 hit
02
Jefferies Financial Group | Investor Presentation Deck | 74 slidesJefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations Beat · Setup1 hit
03
Jefferies Financial Group | Investor Presentation Deck | 74 slidesJefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations Beat · Setup1 hit